Targeting Tregs in MM Dahlhoff et al. 2022

Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression. Julia Dahlhoff, PhD, Andreas Beilhack Lab, Würzburg University Hospital, Germany, Europe, Immunotherapy program targeting regulatory T cells

Tregs FoxP3 Multiple Myeloma Cancer Immunotherapy Triggering an intrinsic anti-cancer immune response